Brief: Century Therapeutics Receives Nasdaq Notice For Bid Price Deficiency
28/02/2025 21:20
Feb 28 (Reuters) - Century Therapeutics Inc IPSC.O: CENTURY THERAPEUTICS INC - RECEIVES NASDAQ NOTICE FOR BID PRICE DEFICIENCY Source text: [ID:n0001104659-25-019145] Further company coverage: IPSC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview